Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 7
2009 3
2011 1
2012 2
2014 4
2015 5
2016 2
2017 3
2018 4
2019 1
2020 2
2021 3
2023 2
2024 5
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Are veterans at increased risk of myeloproliferative neoplasms?
DeStefano CB, Burwick N, Helmer DA. DeStefano CB, et al. Among authors: burwick n. Am J Hematol. 2024 Oct;99(10):1852-1854. doi: 10.1002/ajh.27453. Epub 2024 Aug 9. Am J Hematol. 2024. PMID: 39119902 No abstract available.
Regional variation in financial hardship among US veterans during the COVID-19 pandemic.
Hauschildt KE, Bui DP, Govier DJ, Eaton TL, Viglianti EM, Ettman CK, McCready H, Smith VA, O'Hare AM, Osborne TF, Boyko EJ, Ioannou GN, Maciejewski ML, Bohnert ASB, Hynes DM, Iwashyna TJ; VA COVID-19 Observational Research Collaboratory (CORC). Hauschildt KE, et al. Health Aff Sch. 2024 Jun 5;2(6):qxae075. doi: 10.1093/haschl/qxae075. eCollection 2024 Jun. Health Aff Sch. 2024. PMID: 38938272 Free PMC article.
Self-Reported Everyday Functioning After COVID-19 Infection.
Iwashyna TJ, Smith VA, Seelye S, Bohnert ASB, Boyko EJ, Hynes DM, Ioannou GN, Maciejewski ML, O'Hare AM, Viglianti EM, Berkowitz TS, Pura J, Womer J, Kamphuis LA, Monahan ML, Bowling CB; VA HSR&D COVID-19 Observational Research Collaboratory (CORC). Iwashyna TJ, et al. JAMA Netw Open. 2024 Mar 4;7(3):e240869. doi: 10.1001/jamanetworkopen.2024.0869. JAMA Netw Open. 2024. PMID: 38427352 Free PMC article.
Changes in Outpatient Health Care Use After COVID-19 Infection Among Veterans.
Hebert PL, Kumbier KE, Smith VA, Hynes DM, Govier DJ, Wong E, Kaufman BG, Shepherd-Banigan M, Rowneki M, Bohnert ASB, Ioannou GN, Boyko EJ, Iwashyna TJ, O'Hare AM, Bowling CB, Viglianti EM, Maciejewski ML; VA COVID-19 Observational Research Collaboratory (CORC). Hebert PL, et al. JAMA Netw Open. 2024 Feb 5;7(2):e2355387. doi: 10.1001/jamanetworkopen.2023.55387. JAMA Netw Open. 2024. PMID: 38334995 Free PMC article.
Late Mortality After COVID-19 Infection Among US Veterans vs Risk-Matched Comparators: A 2-Year Cohort Analysis.
Iwashyna TJ, Seelye S, Berkowitz TS, Pura J, Bohnert ASB, Bowling CB, Boyko EJ, Hynes DM, Ioannou GN, Maciejewski ML, O'Hare AM, Viglianti EM, Womer J, Prescott HC, Smith VA; VA HSR&D COVID-19 Observational Research Collaboratory. Iwashyna TJ, et al. JAMA Intern Med. 2023 Oct 1;183(10):1111-1119. doi: 10.1001/jamainternmed.2023.3587. JAMA Intern Med. 2023. PMID: 37603339 Free PMC article.
Phase 2 study of venetoclax plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma.
Costa LJ, Davies FE, Monohan GP, Kovacsovics T, Burwick N, Jakubowiak A, Kaufman JL, Hong WJ, Dail M, Salem AH, Yang X, Masud AA, Munasinghe W, Ross JA, Bueno OF, Kumar SK, Stadtmauer EA. Costa LJ, et al. Among authors: burwick n. Blood Adv. 2021 Oct 12;5(19):3748-3759. doi: 10.1182/bloodadvances.2020004146. Blood Adv. 2021. PMID: 34470049 Free PMC article. Clinical Trial.
Proteins in the antiapoptotic B-cell lymphoma 2 (BCL-2) family play a role in the pathophysiology of multiple myeloma (MM). Venetoclax is a highly selective, potent, oral BCL-2 inhibitor that induces apoptosis of MM cells, and its efficacy may be potentiated through …
Proteins in the antiapoptotic B-cell lymphoma 2 (BCL-2) family play a role in the pathophysiology of multiple myeloma (MM). Ve …
Autologous hematopoietic transplantation following COVID-19 infection.
Brzycki M, Richard R, Burwick N, Graf S, O'Brien C, Wu D, Chauncey TR. Brzycki M, et al. Among authors: burwick n. Clin Case Rep. 2021 Jan 3;9(3):1167-1170. doi: 10.1002/ccr3.3712. eCollection 2021 Mar. Clin Case Rep. 2021. PMID: 33768803 Free PMC article.
Autologous hematopoietic cell transplantation following induction therapy is standard of care for most patients with newly diagnosed multiple myeloma (N Engl J Med 2017, 376; 1311). Though active COVID-19 infection is typically a contraindication to aggressive thera …
Autologous hematopoietic cell transplantation following induction therapy is standard of care for most patients with newly diagnosed mult …
41 results